Guanine nucleotide exchange factor VAV1 (VAV1)

Guanine nucleotide exchange factor VAV1 is a critical signaling protein primarily expressed in hematopoietic cells, where it functions as a master regulator of T-cell and B-cell receptor signaling. It acts as a guanine nucleotide exchange factor (GEF) for Rho family GTPases, such as Rac1, RhoA, and Cdc42, facilitating the transition from an inactive GDP-bound state to an active GTP-bound state to trigger cytoskeletal remodeling and gene transcription. Beyond its catalytic GEF activity, VAV1 serves as a multidomain adaptor protein that coordinates various signaling complexes essential for immune cell activation and calcium mobilization. In the context of disease, VAV1 is frequently mutated or overexpressed in various malignancies, particularly peripheral T-cell lymphomas (PTCL), where it acts as a driver oncogene. Consequently, VAV1 has emerged as a promising therapeutic target for both oncology and autoimmune disorders. Current drug discovery efforts focus on developing small-molecule inhibitors that block its GEF activity or disrupt its SH3 domain interactions to dampen aberrant signaling in cancer and hyper-inflammatory states.

Other names

Vav proto-oncogeneProto-oncogene Vavp95VavVAV

Inhibition of guanine nucleotide exchange activity on Rho family GTPases (specifically Rac1, RhoA, and Cdc42) and disruption of SH3 domain-mediated protein-protein interactions.